CGA
ABBV icon

Crescent Grove Advisors’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.02M Sell
5,470
-1,667
-23% -$309K 0.1% 114
2025
Q1
$1.5M Sell
7,137
-553
-7% -$116K 0.16% 89
2024
Q4
$1.37M Buy
7,690
+2,696
+54% +$479K 0.14% 100
2024
Q3
$986K Sell
4,994
-544
-10% -$107K 0.1% 114
2024
Q2
$950K Sell
5,538
-2,425
-30% -$416K 0.1% 114
2024
Q1
$1.45M Sell
7,963
-200
-2% -$36.4K 0.15% 92
2023
Q4
$1.27M Sell
8,163
-248
-3% -$38.4K 0.14% 99
2023
Q3
$1.25M Sell
8,411
-2,951
-26% -$440K 0.16% 96
2023
Q2
$1.53M Buy
11,362
+4,670
+70% +$629K 0.16% 80
2023
Q1
$1.07M Sell
6,692
-3,893
-37% -$620K 0.12% 101
2022
Q4
$1.71M Buy
10,585
+170
+2% +$27.5K 0.18% 79
2022
Q3
$1.4M Buy
10,415
+6,639
+176% +$891K 0.16% 75
2022
Q2
$578K Sell
3,776
-3,110
-45% -$476K 0.06% 152
2022
Q1
$1.12M Sell
6,886
-74
-1% -$12K 0.11% 102
2021
Q4
$942K Sell
6,960
-718
-9% -$97.2K 0.09% 122
2021
Q3
$828K Buy
7,678
+3,854
+101% +$416K 0.09% 117
2021
Q2
$431K Sell
3,824
-820
-18% -$92.4K 0.05% 161
2021
Q1
$503K Buy
4,644
+1,341
+41% +$145K 0.06% 130
2020
Q4
$354K Buy
3,303
+365
+12% +$39.1K 0.05% 137
2020
Q3
$257K Sell
2,938
-5
-0.2% -$437 0.05% 141
2020
Q2
$289K Hold
2,943
0.06% 118
2020
Q1
$224K Buy
2,943
+78
+3% +$5.94K 0.05% 117
2019
Q4
$254K Sell
2,865
-2,000
-41% -$177K 0.04% 137
2019
Q3
$368K Hold
4,865
0.07% 103
2019
Q2
$354K Sell
4,865
-5,278
-52% -$384K 0.07% 105
2019
Q1
$817K Buy
10,143
+3,100
+44% +$250K 0.17% 65
2018
Q4
$649K Sell
7,043
-5,134
-42% -$473K 0.14% 85
2018
Q3
$1.15M Buy
12,177
+220
+2% +$20.8K 0.25% 52
2018
Q2
$1.11M Sell
11,957
-500
-4% -$46.3K 0.27% 52
2018
Q1
$1.18M Buy
12,457
+500
+4% +$47.3K 0.29% 48
2017
Q4
$1.16M Hold
11,957
0.29% 47
2017
Q3
$1.06M Hold
11,957
0.27% 53
2017
Q2
$867K Buy
+11,957
New +$867K 0.25% 53